I totally agree - bio stocks like this go through various phases and take time to mature.
It is another one that you (IMO) purchase, put in the bottom drawer and let management do what they are paid to do -that is bring a viable product to market, prove the efficacy and load up the truck
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis, page-53
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.5¢ |
Change
-0.001(2.78%) |
Mkt cap ! $94.93M | |||
| Open | High | Low | Value | Volume |
| 3.7¢ | 3.7¢ | 3.4¢ | $220.0K | 6.153M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 265101 | 3.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 175641 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |